Growth Equity

Carnelian Energy Capital funds Azul Resources II, reuniting a successful team to tap the Haynesville Shale, betting big on LNG export demand.

O'Leary Digital unveils a colossal 15-gigawatt plan for AI data centers in Utah and Alberta, but faces environmental backlash and Indigenous opposition.

UK brand Aurelia Cellular Vitality launches in the US, betting its science-led Eternacell™ complex can disrupt the booming ingestible beauty industry.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

As Yellowknife faces a dire housing shortage and rising homelessness, all eyes are on a major federal-territorial announcement. Will it be a lifeline?

The executive compensation firm appoints a new leader with a PE-backed growth record, signaling a strategic push into technology and expanded services.

With $255M from star investors, a firm is betting on a radical idea: that treating employees with dignity is the best way to generate returns.

Gloo's major sponsorship of NRB 2026 signals a new era of AI in faith, but raises critical questions about technology's role in modern spirituality.

With co-founder Tony Ngai now Co-President and CTO, Efinix is scaling its unique FPGA technology to capture the explosive demand in the edge AI market.

A new partnership merges AI speed with human expertise, aiming to redefine corporate due diligence and risk management in an increasingly volatile world.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

The nation's top infectious disease lab partners with SYNERGEN Health, using AI to combat claim denials and future-proof its national expansion.